Drug Delivery
Conventional drug delivery approaches are often not suitable for emerging drugs such as poorly soluble new chemical entities or fragile macromolecules. Additionaly, differentiated drug delivery systems make it possible to maintain a competitive position for existing drugs for as long as possible through the development of controlled-release formulations or alternative routes of administration.
Accordingly, the design of formulation technologies and drug delivery systems leading to enhanced efficacy, tolerance and compliance is taking a predominant role in the pharmaceutical industry to improve drug therapy:
- Long-acting injectable formulations of small drugs and macromolecules.
- Oral bioavailability enhancement of poorly-soluble drugs.
- Reduction of pharmacokinetics variability and food interactions.
- Nasal or pulmonary drug delivery.